Marilla Thorell
Chief Financial Officer
Replay available
Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call
Seres Therapeutics, Inc. (NASDAQ: MCRB) Q3 2024 earnings conference call, held 2024-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Caroline Poacher
Analyst, JP Morgan
Joseph Assome
Analyst, TD Cowan
Dr. Terry Young
Chief Commercial and Strategy Officer
Dr. Lisa Von Mulkey
Chief Medical Officer
Eric Schaaf
President and Chief Executive Officer
Dr. Carlo Tanzi
Investor Relations
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Seres Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.216 Thank you for standing by. My name is Bella and I will be your conference operator 00:00:05.216 -- 00:00:06.637 today. 00:00:06.637 -- 00:00:12.323 At this time, I would like to welcome everyone to the Q3 2024 Series 00:00:12.323 -- 00:00:15.746 Therapeutics Earnings Conference Call. 00:00:15.746 -- 00:00:19.810 All lines have been placed to mute to prevent any background noise. 00:00:19.810 -- 00:00:25.075 After the speaker's remarks, there will be a question and answer session. 00:00:25.075 -- 00:00:30.525 If you would like to ask a question during this time, simply press star followed 00:00:30.525 -- 00:00:36.273 by the number 1 on your telephone keypad. If you would like to withdraw your question, 00:00:36.273 -- 00:00:41.501 press star 1 again. Thank you. I would now like to turn the call over 00:00:41.501 -- 00:00:47.530 to Dr. Carlo Tanzi, Investor Relations. Please go ahead. 00:00:47.530 -- 00:00:52.597 Thank you and good morning. Our press release with the company's third quarter 2024 financial 00:00:52.597 -- 00:00:55.720 results and business updates became available at 7 a.m. 00:00:55.720 -- 00:01:00.125 Eastern time this morning and can be found on the investors and news section of the company's 00:01:00.125 -- 00:01:05.431 website. The company has also posted an updated corporate presentation to the website. 00:01:05.431 -- 00:01:09.636 I'd like to remind you that we'll be making forward-looking statements, including statements 00:01:09.636 -- 00:01:14.701 about the financial terms and future payments related to the VOW sale, the timing and 00:01:14.701 -- 00:01:19.827 results of our clinical studies and data readouts, future product candidates, development 00:01:19.827 -- 00:01:25.124 plans, and commercial opportuniti...